12.15.21
Kiora Pharmaceuticals Appoints David Hollander, MD, MBA, to its Board of Directors
SALT LAKE CITY, UT, Dec 15, 2021 – Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX), (“Kiora” or the “Company”) announced the appointment of David Hollander, MD, MBA, to its Board of Directors....
Read more